ArticleMedical oncology (Northwood, London, England)2017

Sunitinib-induced hypothyroidism predicts progression-free survival in metastatic renal cell carcinoma patients.

Anna Buda-Nowak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.